Is Viveve Right For You?

Solutions for Women's Intimate Health

Clinically Proven

Gentle Single-Session

Comfortable, Quick & Pain Free


More than half of all women experience urogenital symptoms over time which impact intimacy, physical health and quality of life. 

We've been conditioned to think it’s a normal part of aging and that surgery or medication is the only solution.  But with advances in tissue revitalization technology, that's just not true anymore.  Viveve is a nonsurgical, drug-free solution for symptoms of incontinence, vaginal dryness and pelvic organ prolapse. 

Why Viveve?

  • Viveve is for women experiencing incontinence, vaginal dryness and/or pelvic floor laxity due to childbirth, age or hormonal changes.
  • Viveve is clinically proven to promote robust collagen growth and reinvigorate intimate tissues.
  • The Viveve Treatment requires only ONE 30-45 minute treatment to produce scientifically proven results. 
  • No Downtime or recovery required - have the procedure and get right back to living your life.
  • Side effects of Viveve for include:  increased muscle tone, more natural moisture, and greater pleasure during intimacy.
  • Studies have demonstrated a 95% effectiveness rate in multiple clinical trials. 

About the Viveve Process 

  • Viveve delivers radio frequency energy via a cryogenically cooled tip.
  • In response, robust neocollagensis occurs restoring tone and vitality of the tissues. 
  • Because of the patented cooling technology, Viveve can safely and comfortably deliver energy longer and reach more layers of tissue.
  • Over the next 90 days, the body continues making new collagen and symptoms of incontinence, dryness and laxity improve. 
  • In addition, the OptimaLiving Viveve treatment protocol includes biofeedback and pelvic floor therapy to promote long term results.


Open early mornings, evenings and weekends by appointment

8506 W. Deer Valley Rd. Suite 105

Peoria AZ 85382

© OptimaLiving Therapy LLC  I   Policy  I   Disclaimer 

The Viveve System is indicated for the treatment of laxity, intimate health, or urinary incontinence in

50 countries and use in general surgery electrocoagulation and hemostasis in the U.S.   Viveve is currently enrolled

in an IDE study with the FDA for sexual function and stress urinary incontinence.